What development phase is CHEMBL164447 in?

Last reviewed 2026-04-20 · How we verify

CHEMBL164447

Phase 1 active Quality 0/100

At a glance

Generic name	CHEMBL164447
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CHEMBL164447 CI brief — competitive landscape report
CHEMBL164447 updates RSS · CI watch RSS
portfolio CI